U.S.A.
2018 Nominees
AbbVie Inc.
Mavyret
Aerie Pharmaceuticals, Inc.
Rhopressa®
Boehringer Ingelheim Pharmaceuticals, Inc.
Ofev
Boehringer Ingelheim Pharmaceuticals, Inc.
Jardiance®
Bristol Myers Squibb Pharmaceuticals, Inc.
Daklinza™
Celgene-Agios
Idhifa
Eli Lilly and Company
Verzenio
Endoceutics, Inc
Intrarosa™
Janssen Biotech, Inc
Invega Trinza
Janssen Research & Development, LLC
Darzalex
Melinta Therapeutics, Inc
Vabomere
Merck & Co., Inc.
Steglatro
Merck & Co., Inc.
Prevymis
Mitsubishi Tanabe Pharma America
Radicava
Neurocrine Biosciences
Ingrezza™
Novartis Pharmaceuticals Corporation
Rydapt
Pfizer Inc. & Astellas
Xtandi
Portola Pharmaceuticals
Bevyxxa
TESARO, Inc
Zejula
Teva Pharmaceutical Industries Ltd.
Austedo®
Alexion Pharmaceuticals Inc.
Strensiq®
Alexion Pharmaceuticals Inc.
Kanuma®
Boehringer Ingelheim Pharmaceuticals, Inc.
Praxbind
Genentech & Roche
Hemlibra
Gilead Sciences
Yescarta
GlaxoSmithKline
Shingrix
Janssen Research & Development
Tremfya
Merck & Co., Inc.
Zinplava
Novartis Pharmaceuticals Corporation
Kymriah
Pfizer
Trumemba
Regeneron Pharmaceuticals, Inc. & Sanofi
Dupixent
Spark Therapeutics
Luxturna
Ultragenyx Pharmaceutical
Mepsevii
Abbott
FreeStyle Libre – Flash Glucose Monitoring System
Boston Scientific Corporation
AXIOS™ – Stent and Electrocautery Enhanced Delivery System
Boston Scientific Corporation
SpyGlass
Boston Scientific Corporation
Watchman
Brainscope Company, Inc
BrainScope® One
Foundation Medicine, Inc.
FoundationOneCDx
I Integra LifeSciences Corporation, Inc
Omnigraft® Dermal Regeneration Matrix
Koning Corporation, Inc
KBCT 1000
Medtronic
Implantable System for Remodulin
Otsuka America Pharmaceutical Inc. (OAPI), Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) and Proteus Digital Health
Abilify MyCite